Zobrazeno 1 - 10
of 253
pro vyhledávání: '"Fassbender M"'
Autor:
Hu, X., Karnetzke, J., Fassbender, M., Drücker, S., Bettermann, S., Schroeter, B., Pauer, W., Moritz, H.-U., Fiedler, B., Luinstra, G., Smirnova, I.
Publikováno v:
In Chemical Engineering Journal 1 May 2020 387
Autor:
Engle, J. W., Mashnik, S. G., Bach, H., Couture, A., Jackman, K., Gritzo, R., Ballard, B. D., Faßbender, M., Smith, D. M., Bitteker, L. J., Ullmann, J. L., Gulley, M., Pillai, C., John, K. D., Birnbaum, E. R., Nortier, F. M.
Publikováno v:
Nuclear Physics A, 893, 87-100 (2012)
A single terbium foil was irradiated with 800 MeV protons to ascertain the potential for production of lanthanide isotopes of interest in medical, astrophysical, and basic science research and to contribute to nuclear data repositories. Isotopes prod
Externí odkaz:
http://arxiv.org/abs/1207.1486
Autor:
Weidner, J. W., Mashnik, S. G., John, K. D., Hemez, F., Ballard, B., Bach, H., Birnbaum, E. R., Bitteker, L. J., Couture, A., Dry, D., Fassbender, M. E., Gulley, M. S., Jackman, K. R., Ullmann, J. L., Wolfsberg, L. E., Nortier, F. M.
Cross sections for 223,225Ra, 225Ac and 227Th production by the proton bombardment of natural thorium targets were measured at proton energies below 200 MeV. Our measurements are in good agreement with previously published data and offer a complete e
Externí odkaz:
http://arxiv.org/abs/1205.3523
Autor:
Weidner, J. W., Mashnik, S. G., John, K. D., Ballard, B., Birnbaum, E. R., Bitteker, L. J., Couture, A., Fassbender, M. E., Goff, G. S., Gritzo, R., Hemez, F. M., Runde, W., Ullmann, J. L., Wolfsberg, L. E., Nortier, F. M.
Cross sections for the formation of 225,227-Ac, 223,225-Ra, and 227-Th via the proton bombardment of natural thorium targets were measured at a nominal proton energy of 800 MeV. No earlier experimental cross section data for the production of 223,225
Externí odkaz:
http://arxiv.org/abs/1204.2299
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gott, M. D., Wycoff, D. E., Balkin, E. R., Smith, B. E., Fassbender, M. E., Cutler, C. S., Ketring, A. R., Wilbur, D. S., Jurisson, S. S.
Introduction Radioisotopes play an important role in nuclear medicine and represent powerful tools for imaging and therapy. With the extensive use of 99mTc-based imaging agents, therapeutic rhenium analogues are highly desirable. Rhenium-186 emits th
Externí odkaz:
https://hzdr.qucosa.de/id/qucosa%3A22242
https://hzdr.qucosa.de/api/qucosa%3A22242/attachment/ATT-0/
https://hzdr.qucosa.de/api/qucosa%3A22242/attachment/ATT-0/
Autor:
Nortier, F. M., Bach, H. T., Birnbaum, E. R., Engle, J. W., Fassbender, M. E., Hunter, J. F., John, K. D., Marr-Lyon, M., Moddrell, C., Moore, E. W., Olivas, E. R., Quintana, M. E., Seitz, D. N., Taylor, W. A.
Strontium-82 (t1/2 = 25.5 d) is one of the medical isotopes produced on a large scale at the Isotope Production Facility (IPF) of the Los Alamos National Laboratory (LANL), employing a high intensity 100 MeV proton beam and RbCl targets. A constant i
Externí odkaz:
https://hzdr.qucosa.de/id/qucosa%3A22234
https://hzdr.qucosa.de/api/qucosa%3A22234/attachment/ATT-0/
https://hzdr.qucosa.de/api/qucosa%3A22234/attachment/ATT-0/
Autor:
Balkin, E. R., Strong, K. T., Smith, B. E., Gagnon, K., Dorman, E., Emery, R., Pauzauskie, P., Fassbender, M. E., Cutler, C. S., Ketring, A. R., Jurisson, S. S., Wilbur, D. S.
Introduction Rhenium-186 (t1/2 = 3.72 d) is very attractive for use as a theranostic agent in targeted radionuclide therapy (Eβ max = 1.072 MeV (> 76.6 %); Eγ = 137.2 keV)1. Previously published investigations of high specific activity 186Re produc
Externí odkaz:
https://hzdr.qucosa.de/id/qucosa%3A22232
https://hzdr.qucosa.de/api/qucosa%3A22232/attachment/ATT-0/
https://hzdr.qucosa.de/api/qucosa%3A22232/attachment/ATT-0/
Autor:
Balkin, E. R., Gagnon, K., Dorman, E., Emery, R., Smith, B. E., Strong, K. T., Pauzauskie, P., Fassbender, M. E., Cutler, C. S., Ketring, A. R., Jurisson, S. S., Wilbur, D. S.
Rhenium-186 has a half-life (t1/2 = 3.72 days) and emission of both gamma and beta particles that make it very attractive for use as a theranostic agent in targeted radionuclide therapy. 186Re can be readily prepared by the 185Re(n,γ)186Re reac-tion
Externí odkaz:
https://hzdr.qucosa.de/id/qucosa%3A22231
https://hzdr.qucosa.de/api/qucosa%3A22231/attachment/ATT-0/
https://hzdr.qucosa.de/api/qucosa%3A22231/attachment/ATT-0/
Autor:
Engle, J. W., Marus, L. A., Cooley, J. C., Maassen, J. R., Quintana, M. E., Taylor, W. A., Wilson, J. J., Radchenko, V., Fassbender, M. E., John, K. D., Birnbaum, E. R., Nortier, F. M.
Introduction The Los Alamos Isotope Production Program commonly irradiates target stacks consisting of high, medium and low-energy targets in the “A-”, “B-”, and “C-slots”, respectively, with a 100MeV proton beam. The Program has recently
Externí odkaz:
https://hzdr.qucosa.de/id/qucosa%3A22230
https://hzdr.qucosa.de/api/qucosa%3A22230/attachment/ATT-0/
https://hzdr.qucosa.de/api/qucosa%3A22230/attachment/ATT-0/